By Ethan Covey
The prevalence of drug-resistant pathogens (DRPs) in a patient population may be underestimated when calculated using the drug resistance in pneumonia (DRIP) score, according to data presented at IDWeek 2022, held in Washington, D.C.
“The 2019 [American Thoracic Society/Infectious Diseases Society of America] community-acquired pneumonia (CAP) guidelines recommended abandoning the definition of healthcare-associated pneumonia (HCAP) and to base the need for broad-spectrum